Al-Hikmah, Dr. Reddy's license Nicotinel MENA
Alhamdah Pharmaceutical Technologies has signed an exclusive agreement with Dr. Reddy's Laboratories to register and distribute Nicotinell in the Middle East and North Africa region. Nicotinell, an alternative option for treating nicotine addiction, is used to help smokers quit through products like patches, gum, lozenges, and sprays. Smoking rates are high in the region, and related diseases account for about 22% of causes of death, highlighting the need for effective cessation solutions. Alhamdah will gradually introduce Nicotinell into local markets, aiming to improve public health outcomes by providing reliable treatment options to help smokers quit.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)